This is a StreetInsider.com Premium Only Page

(GMDA) – StreetInsider.com Reports

Apr 8, 2024 07:44 AM XORTX Therapeutics (XRTX) Welcomes New Member to the Board of Directors

Mar 27, 2024 07:02 AM Gamida Cell (GMDA) Announces Commencement of Restructuring Process Supported by Highbridge Capital Management

Jan 29, 2024 12:24 PM JMP Securities Downgrades Gamida Cell Ltd. (GMDA) to Market Perform, 'Stepping to the sidelines as Gamida explores strategic alternatives'

Jan 29, 2024 06:01 AM Gamida Cell (GMDA) Pursuing Strategic Alternatives

Nov 15, 2023 05:27 PM Gamida Cell Ltd. (GMDA) Files $150M Mixed Shelf

Nov 15, 2023 06:43 AM Gamida Cell Ltd. (GMDA) PT Lowered to $2 at Piper Sandler

Nov 15, 2023 06:37 AM Gamida Cell Ltd. (GMDA) PT Lowered to $5 at H.C. Wainwright

Nov 14, 2023 07:04 AM Gamida Cell Ltd. (GMDA) Tops Q3 EPS by 18c

Oct 16, 2023 04:39 PM Gamida Cell (GMDA) Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201

Oct 9, 2023 02:01 PM Gamida Cell (GMDA) Issues Update on Israel Operations

Sep 27, 2023 04:30 PM Gamida Cell (GMDA) Reports First Patient Receives Omisirge

Aug 14, 2023 07:30 AM Gamida Cell Ltd. (GMDA) Misses Q2 EPS by 11c

May 19, 2023 02:20 AM Gamida Cell Ltd. (GMDA) PT Lowered to $6 at JMP Securities

May 16, 2023 07:37 AM Gamida Cell Ltd. (GMDA) PT Lowered to $6 at Oppenheimer

Apr 20, 2023 07:13 AM Gamida Cell Ltd. (GMDA) PT Lowered to $6 at Needham & Company

Apr 20, 2023 06:57 AM Gamida Cell Ltd. (GMDA) PT Raised to $11 at H.C. Wainwright

Apr 19, 2023 08:15 AM Gamida Cell Ltd. (GMDA) Prices $23 Million Public Offering of Ordinary Shares, Warrants

Apr 19, 2023 05:46 AM Gamida Cell Ltd. (GMDA) Launches Share Offering, Size not Disclosed

Apr 19, 2023 05:04 AM Increasing unusual option volume: GMDA WAL ZION FRC GPN

Apr 18, 2023 06:18 AM Gamida Cell Ltd. (GMDA) surges on FDA approval for cell therapy Omisirge

Apr 17, 2023 04:16 PM Gamida Cell Ltd. (GMDA) Announces FDA Approval of Omisirge

Mar 28, 2023 08:29 AM Gamida Cell Ltd. (GMDA) PT Lowered to $8 at Oppenheimer

Mar 28, 2023 06:36 AM Gamida Cell Ltd. (GMDA) PT Lowered to $5 at H.C. Wainwright

Mar 28, 2023 05:26 AM Gamida Cell Ltd. (GMDA) PT Lowered to $5 at Piper Sandler

Mar 20, 2023 04:30 PM Gamida Cell (GMDA) Announces Changes to Board of Directors

Jan 11, 2023 04:05 PM Gamida Cell Ltd. (GMDA) Announces 14.67M Share Offering by Selling Stockholders

Nov 21, 2022 04:53 PM Gamida Cell Ltd. (GMDA) Provides Update on Omidubicel

Nov 15, 2022 07:41 AM Gamida Cell Ltd. (GMDA) PT Lowered to $10 at Oppenheimer

Nov 14, 2022 07:16 AM Gamida Cell Ltd. (GMDA) Tops Q3 EPS by 2c

Nov 7, 2022 08:14 AM Gamida Cell Ltd. (GMDA) Announces GDA-501, NAM enabled NK Cell Therapy, Demonstrates Promising Antitumor Activity Against HER2+ Cancers

Oct 3, 2022 08:56 AM Gamida Cell Ltd. (GMDA) PT Lowered to $7 at Piper Sandler

Sep 29, 2022 07:04 AM Gamida Cell (GMDA) Announces Long-Term Data from Omidubicel Phase 3 Trial Demonstrates OS and Sustainable Durable Outcomes for Patients with Blood Cancers

Sep 28, 2022 05:57 AM Gamida Cell Ltd. (GMDA) Prices 12.9M Share Offering at $1.55/sh

Sep 27, 2022 04:06 PM Gamida Cell Ltd. (GMDA) Launches Share Offering, Size not Disclosed

Sep 19, 2022 07:03 AM Gamida Cell (GMDA) Appoints Abigail L. Jenkins as President and Chief Executive Officer

Aug 15, 2022 07:04 AM Gamida Cell Ltd. (GMDA) Misses Q2 EPS by 2c

Aug 1, 2022 07:03 AM Gamida Cell (GMDA) Announces FDA Acceptance of Biologics License Application for Omidubicel with Priority Review

Jun 2, 2022 07:03 AM Gamida Cell Ltd. (GMDA) Completes Rolling Omidubicel BLA Submission to FDA

May 17, 2022 07:01 AM MediWound (MDWD) Appoints Ofer Gonen as New CEO

May 10, 2022 07:21 AM Gamida Cell Ltd. (GMDA) Reports In-Line Q1 EPS

May 5, 2022 07:08 AM Gamida Cell Ltd. (GMDA) Presents New Data from NAM-Enabled Genetically Modified Natural Killer (NK) Pipeline

Apr 27, 2022 07:00 AM Gamida Cell Ltd. (GMDA) Reports Updated One-Year Post-Transplant Follow Up Data from Phase 3 Study of Omidubicel

Apr 26, 2022 02:18 PM Needham & Company Reiterates Buy Rating, $12 Price Target on Gamida Cell (GMDA)

Apr 26, 2022 08:54 AM Pre-Open Stock Movers 04/26: MagnaChip Gains on Deal Talk; Universal Health, GE Dip on Earnings (more...)

Apr 26, 2022 07:11 AM Gamida Cell (GMDA) Climbs 33% After Announcing FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201

Apr 26, 2022 07:00 AM Gamida Cell Ltd. (GMDA) Announces FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201

Apr 26, 2022 05:45 AM Gamida Cell (GMDA) Presents Updated Omidubicel Data

Apr 25, 2022 07:02 AM Gamida Cell Ltd. (GMDA) Announces Results of New Health Economic and Outcome Study Reporting Improved Health Equity and Health Outcomes With Omidubicel at 2022 Transplantation & Cellular Therapy Meeti

Mar 16, 2022 06:18 AM Oppenheimer Reiterates Gamida Cell (GMDA) at Outperform, $15 PT, Sees Potential omidubicel Approval in 1H23

Feb 9, 2022 07:00 AM Gamida Cell Ltd. (GMDA) Initiates Rolling Submission of Biologics License Application for Omidubicel